Home > Resources > Whitepapers > Real-Time Temperature Monitoring for Pharma Cold Chain Logistics

Real-Time Temperature Monitoring for Pharma Cold Chain Logistics

July 23, 2019

When it comes to safely and securely transporting high value pharmaceutical products, the stakes couldn’t be higher. Not only is a single consignment of high value drugs potentially worth upwards of $50 million, but, for those patients in need of these drugs, ensuring these products arrive on time and in optimal condition is quite literally a matter of life and death.

Spotlight

Pharmaceutical Society of Australia

The Pharmaceutical Society of Australia (the 'Society') is the Peak National Body for all Australian pharmacists. The Society was established by the state professional pharmaceutical societies in 1977, some of which had been in existence for over 100 years. Its provides the profession with a national identity, an opportunity to effectively regulate its affairs, and achieve better coordination in consultation and liaison with the Commonwealth Government, other professions and industry. The Society supports pharmacists’ commitment to high standards of patient care and continuing professional education, and represent their role as frontline health professionals; and is the leading advocacy organisation for pharmacists, influencing attitudes, opinions and policies through representation, networking, consultation, continuing education, practice support, standards, guidelines and a range of publications and health promoting programs and resources.

OTHER WHITEPAPERS

Unlocking iPSCs to Improve CNS Modeling and Drug Discovery

whitePaper | June 15, 2022

To date, therapeutic advances in treating central nervous system (CNS) disorders have been incremental at best. As the global population increases and older demographics begin to make up a disproportionately larger percentage,

Drug Solubility and the Need for Speed

whitePaper | March 28, 2023

About 70% of new chemical entities (NCEs) are highly insoluble.1 It’s a fact that troubles small biotechnology companies and other drug manufacturers. Indeed, insoluble drugs present a wide range of challenges during development and, if not addressed, can ultimately render drugs ineffective in patients.

The Annual Clinical Trials Round-up 2021

whitePaper | October 13, 2022

In our previous edition of the Clinical Trials Roundup1, we explored the acute disruptions that the COVID-19 pandemic brought to the clinical trials landscape in 2020.

Artificial Intelligence in Drug Manufacturing

whitePaper | May 25, 2023

CDER’s mission is to ensure that human drugs are safe and effective, meet established quality standards, and are available to patients. To advance this mission, FDA’s Pharmaceutical Quality for the 21st Century Initiative promotes an efficient, agile, and flexible pharmaceutical manufacturing sector that reliably produces quality drugs without excessive regulatory oversight.

MOLECULAR GLUES LANDSCAPE IN DRUG DISCOVERY

whitePaper | June 21, 2022

nduced-proximity targeted protein degradation (TPD) is a ground-breaking strategy in drug discovery that has emerged during the last decade.

The Globalization Of The Pharmaceutical Industry

whitePaper | July 7, 2023

Rapid globalization has brought both opportunity and challenges for the pharmaceutical industry. Established healthcare markets are placing increased demands on industry to ensure products are beneficial, safe and available for patients and to improve how information is shared.

Real-Time Temperature Monitoring for Pharma Cold Chain Logistics